Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Lipid Research

• Publication date

  1998-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 9548597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease.

  1996cited by this paper
• Apolipoprotein E1-Hammersmith (Lys146-->Asn;Arg147-->Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia.

  1996cited by this paper
• Human Apolipoprotein E Receptor 2

  1996cited by this paper
• Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136-->Ser) variant in multigenerational pedigree studies.

  1996cited by this paper
• Elements of Neural Adhesion Molecules and a Yeast Vacuolar Protein Sorting Receptor Are Present in a Novel Mammalian Low Density Lipoprotein Receptor Family Member*

  1996cited by this paper
• A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia.

  1996cited by this paper
• Apolipoprotein E2 (Arg‐136→Cys), a variant of apolipoprotein E associated with late‐onset dominance of type III hyperlipoproteinaemia

  1996cited by this paper
• Novel mechanism for defective receptor binding of apolipoprotein E2 in type III hyperlipoproteinemia

  1996cited by this paper
• Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation.

  1995cited by this paper
• Identification and characterization of a novel apolipoprotein E variant, apolipoprotein E3' (Arg136-->His): association with mild dyslipidemia and double pre-beta very low density lipoproteins.

  1995cited by this paper
• Apolipoprotein E isoforms and rare mutations: parallel reduction in binding to cells and to heparin reflects severity of associated type III hyperlipoproteinemia.

  1995cited by this paper
• Determination of triglycerides in lipoproteins separated by agarose gel electrophoresis.

  1995cited by this paper
• Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping.

  1994cited by this paper
• Salt bridge relay triggers defective LDL receptor binding by a mutant apolipoprotein.

  1994cited by this paper
• Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.

  1994cited by this paper
• Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.

  1994cited by this paper
• Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.

  1993cited by this paper
• Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia.

  1992cited by this paper
• Heterozygosity for apolipoprotein E-4Philadelphia(Glu13----Lys, Arg145----Cys) is associated with incomplete dominance of type III hyperlipoproteinemia.

  1992cited by this paper
• Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity.

  1992cited by this paper
• Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.

  1992cited by this paper
• Baculovirus expression vectors: a laboratory manual.

  1992cited by this paper
• Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E.

  1991cited by this paper
• Cloning and sequencing of bovine apolipoprotein E complementary DNA and molecular evolution of apolipoproteins E, C-I, and C-II

  1991cited by this paper
• Baculovirus-mediated expression of human apolipoprotein E in Manduca sexta larvae generates particles that bind to the low density lipoprotein receptor.

  1991cited by this paper
• Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree.

  1991cited by this paper
• Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis.

  1991cited by this paper
• Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia.

  1991cited by this paper
• Phenotyping of apolipoprotein E by immunoblotting in immobilized pH gradients

  1991cited by this paper
• Genetic heterogeneity in familial dysbetalipoproteinemia. The E2(lys146----gln) variant results in a dominant mode of inheritance.

  1990cited by this paper
• Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

  1990cited by this paper
• Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia.

  1989cited by this paper
• Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.

  1989cited by this paper
• Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121-127.

  1989cited by this paper
• Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.

  1989cited by this paper
• Genotyping and sequence analysis of apolipoprotein E isoforms.

  1988cited by this paper
• Crystallization and preliminary X-ray diffraction studies on the amino-terminal (receptor-binding) domain of human apolipoprotein E3 from serum very low density lipoproteins.

  1988cited by this paper
• Apolipoprotein E polymorphism and atherosclerosis.

  1988cited by this paper
• Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions.

  1988cited by this paper
• Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

  1988cited by this paper
• Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.

  1987cited by this paper
• Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.

  1986cited by this paper
• Receptor-mediated endocytosis of low-density lipoprotein in cultured cells.

  1983cited by this paper
• Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.

  1983cited by this paper
• Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.

  1983cited by this paper
• Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.

  1982cited by this paper
• Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.

  1982cited by this paper
• Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms.

  1981cited by this paper
• Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.

  1981cited by this paper
• Human apolipoprotein A-IV. Intestinal origin and distribution in plasma.

  1980cited by this paper
• Cell surface receptor binding of phospholipid . protein complexes containing different ratios of receptor-active and -inactive E apoprotein.

  1980cited by this paper
• Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts.

  1979cited by this paper
• Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

  1977cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Analysis of lipids and lipoproteins

  1975cited by this paper
• Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

  1974cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper

• Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy.

  2017cites this paper
• Update on the molecular biology of dyslipidemias.

  2016cites this paper
• Role of apolipoprotein E in neurodegenerative diseases

  2015cites this paper
• Dysbetalipoproteinaemia: A mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E

  2014cites this paper
• Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia

  2014cites this paper
• Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.

  2010cites this paper
• Selection on Alleles Affecting Human Longevity and Late-Life Disease: The Example of Apolipoprotein E

  2010cites this paper
• Disruption of blood-brain barrier function by chronic intake of saturated fat and cholesterol : implications for Alzheimer’s disease risk

  2010cites this paper
• Apolipoprotein E Arg136 → Cys in Individuals with Premature Myocardial Infarction

  2009cites this paper
• Apolipoprotein E Arg136 --> Cys in individuals with premature myocardial infarction.

  2009cites this paper
• Apolipoprotein E Arg136 --> Cys mutation and hyperlipidemia in a large central European population sample.

  2008cites this paper
• Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism

  2008cites this paper
• ApoE: Crossroads between Alzheimer's Disease and Atherosclerosis

  2004cites this paper
• Two Italian kindreds carrying the Arg136-->Ser mutation of the Apo E gene: development of premature and severe atherosclerosis in the presence of epsilon 2 as second allele.

  2003cites this paper
• Familial dysbetalipoproteinemia in three patients with apoE 2*(Arg136-->Cys) gene variant.

  2003cites this paper
• Apolipoprotein E3Basel: new insights into a highly conserved protein region

  2003cites this paper
• Apolipoprotein E1 Baden (Arg(180)-->Cys). A new apolipoprotein E variant associated with hypertriglyceridemia.

  2001cites this paper
• Identification of an apolipoprotein(e) variant associated with type III hyperlipoproteinaemia in an indigenous Australian

  2001cites this paper
• New Insights into the Heparan Sulfate Proteoglycan-binding Activity of Apolipoprotein E*

  2001cites this paper
• Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.

  2001cites this paper
• Apolipoprotein E polymorphism: Automated determination of apolipoprotein E2, E3, and E4 isoforms

  2000cites this paper
• Differential effects of apolipoprotein E isoforms on phosphorylation at specific sites on tau by glycogen synthase kinase‐3β identified by nano‐electrospray mass spectrometry

  2000cites this paper
• The molecular mechanisms of inherited hypercholesterolemia

  2000cites this paper
• Identification of an apolipoprotein(e) variant associated with type III hyperlipoproteinaemia in an indigenous Australian.

  2000cites this paper
• Competition of Aβ amyloid peptide and apolipoprotein E for receptor-mediated endocytosis

  1999cites this paper
• Application of electrophoretic techniques to the diagnosis of disorders of lipoprotein metabolism. Examples at the levels of lipoproteins and apolipoproteins

  1999cites this paper
• Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis.

  1999cites this paper